Literature DB >> 29496831

Closed Genome Sequence of Vibrio cholerae O1 El Tor Inaba Strain A1552.

Anna Allué-Guardia1,2, Mylea Echazarreta1,2, Sara S K Koenig1,2, Karl E Klose1,2, Mark Eppinger3,2.   

Abstract

Vibrio cholerae is a Gram-negative waterborne human pathogen and the causative agent of cholera. Here, we present the complete genome sequence of the seventh pandemic O1 biovar El Tor Inaba strain A1552 isolated in 1992. This clinical strain has served as an important model strain for studying cholera pathogenicity traits.
Copyright © 2018 Allué-Guardia et al.

Entities:  

Year:  2018        PMID: 29496831      PMCID: PMC5834340          DOI: 10.1128/genomeA.00098-18

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Vibrio cholerae is a waterborne pathogen that represents a public health threat affecting 3 to 5 million people worldwide (1–4). Infections are associated with the toxigenic O1 serogroup, comprised of two main biotypes, classical and El Tor, which evolved from independent lineages (5). Pathogenicity in humans is linked to two major virulence determinants, cholera toxin (CT) (6) produced by the filamentous bacteriophage CTXφ (7, 8) and the toxin-coregulated pilus (TCP) (9). When ingested, the motile bacterium propels itself toward epithelial cells of the small intestine and adheres to the apical surface, where TCP mediates colonization of the epithelial cells and CT stimulates water and electrolyte loss from the intestine, causing severe dehydration and the characteristic “rice waterdiarrhea (10, 11). Cholera pathogenesis relies on the synergistic effect of a number of pathogenicity determinants, including the ToxR signaling and quorum-sensing pathways, which coordinately regulate diverse virulence genes (12, 13). The sequenced O1 biovar El Tor Inaba strain A1552 was isolated in 1992 from a traveler from Peru (14) at the beginning of the South American cholera outbreak in the 1990s (15, 16). Total genomic DNA was extracted with the QIAamp DNA minikit (Qiagen) following the manufacturer’s instructions. To generate a high-quality closed genome, we pursued a hybrid approach using long-read and short-read sequencing on the Oxford Nanopore MinION Mk1B and Illumina MiSeq platforms, respectively. Libraries were prepared using the Nanopore ligation sequencing kit 1D (R9 version) for MinION sequencing, and a paired-end library was prepared using the Nextera XT DNA library preparation kit (Illumina) and the MiSeq V3 600-cycle reagent kit (Illumina) for Illumina sequencing. Nanopore and Illumina reads were used to perform a hybrid assembly using SPAdes (17). Hybrid assembly yielded two circular high-coverage (125× and 112×) chromosomes (18) with genome sizes of 3,015,092 bp and 1,0703,71 bp and GC contents of 47.7% and 46.9% for chromosomes 1 and 2, respectively, in accordance with findings for other V. cholerae O1 genomes (18). The chromosomes were annotated using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) (19). A whole-genome-derived phylogeny (data not shown) identified other O1 El Tor strains as closest relatives, including the Inaba model strain N16961 (18, 20, 21). For virulence and resistance profiling, A1552 gene and protein inventories were queried against V. cholerae virulence and resistance databases (22, 23). Strain A1552 carries genetic hallmarks of the El Tor biotype, such as the tcp operon, the CTXφ bacteriophage hemolysin genes, and genes associated with the ToxR regulon (24–26). In silico antimicrobial susceptibility testing by ResFinder (23) revealed that the smaller chromosome carries the chloramphenicol resistance gene catB9. This strain is also streptomycin resistant, mediated by a mutation (K88R) on the large chromosome within the 30S ribosomal subunit protein RpsL, as described previously (27, 28). The availability of the complete and closed genome will provide the blueprint for better understanding pathogenesis traits in this important prototypical O1 model strain.

Accession number(s).

The annotated chromosomes have been deposited in GenBank under accession numbers CP025936 and CP025937.
  28 in total

Review 1.  Quorum sensing: cell-to-cell communication in bacteria.

Authors:  Christopher M Waters; Bonnie L Bassler
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

2.  Identification of residues critical for the function of the Vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis.

Authors:  Brandon M Childers; Gregor G Weber; Michael G Prouty; Melissa M Castaneda; Fen Peng; Karl E Klose
Journal:  J Mol Biol       Date:  2007-01-27       Impact factor: 5.469

Review 3.  Filamentous phages linked to virulence of Vibrio cholerae.

Authors:  Brigid M Davis; Matthew K Waldor
Journal:  Curr Opin Microbiol       Date:  2003-02       Impact factor: 7.934

4.  Analysis of mutations in streptomycin-resistant strains reveals a simple and reliable genetic marker for identification of the Mycobacterium tuberculosis Beijing genotype.

Authors:  Cristina Villellas; Liselotte Aristimuño; María-Asunción Vitoria; Cristina Prat; Silvia Blanco; Darío García de Viedma; José Domínguez; Sofía Samper; José A Aínsa
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

5.  Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea.

Authors:  Eric J Nelson; Ashrafuzzaman Chowdhury; Jason B Harris; Yasmin A Begum; Fahima Chowdhury; Ashraful I Khan; Regina C Larocque; Anne L Bishop; Edward T Ryan; Andrew Camilli; Firdausi Qadri; Stephen B Calderwood
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-16       Impact factor: 11.205

6.  DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae.

Authors:  J F Heidelberg; J A Eisen; W C Nelson; R A Clayton; M L Gwinn; R J Dodson; D H Haft; E K Hickey; J D Peterson; L Umayam; S R Gill; K E Nelson; T D Read; H Tettelin; D Richardson; M D Ermolaeva; J Vamathevan; S Bass; H Qin; I Dragoi; P Sellers; L McDonald; T Utterback; R D Fleishmann; W C Nierman; O White; S L Salzberg; H O Smith; R R Colwell; J J Mekalanos; J C Venter; C M Fraser
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

7.  Identification of acquired antimicrobial resistance genes.

Authors:  Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen
Journal:  J Antimicrob Chemother       Date:  2012-07-10       Impact factor: 5.790

8.  Evolution of seventh cholera pandemic and origin of 1991 epidemic, Latin America.

Authors:  Connie Lam; Sophie Octavia; Peter Reeves; Lei Wang; Ruiting Lan
Journal:  Emerg Infect Dis       Date:  2010-07       Impact factor: 6.883

9.  Genomic epidemiology of the Haitian cholera outbreak: a single introduction followed by rapid, extensive, and continued spread characterized the onset of the epidemic.

Authors:  Mark Eppinger; Talima Pearson; Sara S K Koenig; Ofori Pearson; Nathan Hicks; Sonia Agrawal; Fatemeh Sanjar; Kevin Galens; Sean Daugherty; Jonathan Crabtree; Rene S Hendriksen; Lance B Price; Bishnu P Upadhyay; Geeta Shakya; Claire M Fraser; Jacques Ravel; Paul S Keim
Journal:  MBio       Date:  2014-11-04       Impact factor: 7.867

10.  Phylogenetic Diversity of Vibrio cholerae Associated with Endemic Cholera in Mexico from 1991 to 2008.

Authors:  Seon Young Choi; Shah M Rashed; Nur A Hasan; Munirul Alam; Tarequl Islam; Abdus Sadique; Fatema-Tuz Johura; Mark Eppinger; Jacques Ravel; Anwar Huq; Alejandro Cravioto; Rita R Colwell
Journal:  MBio       Date:  2016-03-15       Impact factor: 7.867

View more
  8 in total

1.  Natural Transformation in a Classical-Biotype Vibrio cholerae Strain.

Authors:  Cameron J Lloyd; Adrian Mejia-Santana; Triana N Dalia; Ankur B Dalia; Karl E Klose
Journal:  Appl Environ Microbiol       Date:  2021-04-27       Impact factor: 4.792

2.  Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection.

Authors:  Bolutife Fakoya; Karthik Hullahalli; Daniel H F Rubin; Deborah R Leitner; Roma Chilengi; David A Sack; Matthew K Waldor
Journal:  mBio       Date:  2022-04-07       Impact factor: 7.786

3.  Flagella-dependent inhibition of biofilm formation by sub-inhibitory concentration of polymyxin B in Vibrio cholerae.

Authors:  Sean Giacomucci; Candice Danabé-Nieto Cros; Xavier Perron; Annabelle Mathieu-Denoncourt; Marylise Duperthuy
Journal:  PLoS One       Date:  2019-08-20       Impact factor: 3.240

4.  Pathogenomes of Atypical Non-shigatoxigenic Escherichia coli NSF/SF O157:H7/NM: Comprehensive Phylogenomic Analysis Using Closed Genomes.

Authors:  Emmanuel C Nyong; Sam R Zaia; Anna Allué-Guardia; Armando L Rodriguez; Zaina Irion-Byrd; Sara S K Koenig; Peter Feng; James L Bono; Mark Eppinger
Journal:  Front Microbiol       Date:  2020-04-15       Impact factor: 5.640

5.  Experimental evolution of Vibrio cholerae identifies hypervesiculation as a way to increase motility in the presence of polymyxin B.

Authors:  Sean Giacomucci; Annabelle Mathieu-Denoncourt; Antony T Vincent; Hanen Jannadi; Marylise Duperthuy
Journal:  Front Microbiol       Date:  2022-08-22       Impact factor: 6.064

6.  Recent Vibrio cholerae O1 Epidemic Strains Are Unable To Replicate CTXΦ Prophage Genome.

Authors:  Kaoru Ochi; Tamaki Mizuno; Prosenjit Samanta; Asish K Mukhopadhyay; Shin-Ichi Miyoshi; Daisuke Imamura
Journal:  mSphere       Date:  2021-06-09       Impact factor: 4.389

7.  'Community evolution' - laboratory strains and pedigrees in the age of genomics.

Authors:  Matthew J Dorman; Nicholas R Thomson
Journal:  Microbiology (Reading)       Date:  2020-03       Impact factor: 2.777

8.  Genomics of the Argentinian cholera epidemic elucidate the contrasting dynamics of epidemic and endemic Vibrio cholerae.

Authors:  Matthew J Dorman; Daryl Domman; Tomás Poklepovich; Charlotte Tolley; Gisella Zolezzi; Leanne Kane; María Rosa Viñas; Marcela Panagópulo; Miriam Moroni; Norma Binsztein; María Inés Caffer; Simon Clare; Gordon Dougan; George P C Salmond; Julian Parkhill; Josefina Campos; Nicholas R Thomson
Journal:  Nat Commun       Date:  2020-10-01       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.